Related references
Note: Only part of the references are listed.Biopharmaceutical benchmarks 2018
Gary Walsh
NATURE BIOTECHNOLOGY (2018)
Progress in biopharmaceutical development
Malgorzata Kesik-Brodacka
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2018)
FX knockout CHO hosts can express desired ratios of fucosylated or afucosylated antibodies with high titers and comparable product quality
Salina Louie et al.
BIOTECHNOLOGY AND BIOENGINEERING (2017)
Arabinosylation of recombinant human immunoglobulin-based protein therapeutics
Patrick Hossler et al.
MABS (2017)
Fucosyltransferases produce N-glycans containing core L-galactose
Hiroyuki Ohashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Inactivation of GDP-fucose transporter gene (Slc35c1) in CHO cells by ZFNs, TALENs and CRISPR-Cas9 for production of fucose-free antibodies
Kah Fai Chan et al.
BIOTECHNOLOGY JOURNAL (2016)
Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
Jennifer Dumont et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2016)
Inactivation of GDP-fucose transporter gene (Slc35c1) in CHO cells by ZFNs, TALENs and CRISPR-Cas9 for production of fucose-free antibodies
Kah Fai Chan et al.
BIOTECHNOLOGY JOURNAL (2016)
Recombinant production and characterization of human anti-influenza virus monoclonal antibodies identified from hybridomas fused with human lymphocytes
Ryo Misaki et al.
BIOLOGICALS (2016)
Posttranslational Modifications and the Immunogenicity of Biotherapeutics
Roy Jefferis
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications
Anshu Kuriakose et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
What's fueling the biotech engine-2012 to 2013
Saurabh Rob Aggarwal
NATURE BIOTECHNOLOGY (2014)
Tissue-Specific Posttranslational Modification Allows Functional Targeting of Thyrotropin
Keisuke Ikegami et al.
CELL REPORTS (2014)
Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection
Tadahiro Sasaki et al.
ANTIVIRAL RESEARCH (2013)
CHO-gmt5, a novel CHO glycosylation mutant for producing afucosylated and asialylated recombinant antibodies
Ryan Haryadi et al.
BIOENGINEERED (2013)
Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation
Darius Ghaderi et al.
BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS VOL 28, ISSUE 1 (2012)
Identification of functional elements of the GDP-fucose transporter SLC35C1 using a novel Chinese hamster ovary mutant
Peiqing Zhang et al.
GLYCOBIOLOGY (2012)
Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcy receptor binding and antibody-dependent cell-mediated cytotoxicity activities
Shan Chung et al.
MABS (2012)
Highly Efficient Deletion of FUT8 in CHO Cell Lines Using Zinc-Finger Nucleases Yields Cells That Produce Completely Nonfucosylated Antibodies
Laetitia Malphettes et al.
BIOTECHNOLOGY AND BIOENGINEERING (2010)
Decrease in Antithrombin III Fucosylation by Expressing GDP-fucose Transporter siRNA in Chinese Hamster Ovary Cells
Takeshi Omasa et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2008)
Double knockdown of α1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells:: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC
Harue Imai-Nishiya et al.
BMC BIOTECHNOLOGY (2007)
Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: A new strategy for generating completely non-fucosylated recombinant therapeutics
Yutaka Kanda et al.
JOURNAL OF BIOTECHNOLOGY (2007)
Post-translational modifications in the context of therapeutic proteins
Gary Walsh et al.
NATURE BIOTECHNOLOGY (2006)
Establishment of FUT8 knockout Chinese hamster ovary cells:: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity
N Yamane-Ohnuki et al.
BIOTECHNOLOGY AND BIOENGINEERING (2004)
Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA
K Mori et al.
BIOTECHNOLOGY AND BIOENGINEERING (2004)
Fucose: biosynthesis and biological function in mammals
DJ Becker et al.
GLYCOBIOLOGY (2003)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
